HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

The following is the transcript of an interview with former FDA commissioner Scott Gottlieb, Pfizer board member and ...

Gilead's twice-yearly PrEP drug is cleared by FDA. Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?

FORMER drug users are among the vulnerable groups who often face significant barriers in accessing healthcare, including oral ...

Serious concerns continue to be raised on the impact of HIV, as eight children were part of the 126 people who died from HIV-related illnesses in the ...